ArticleBMJ public health2025
Cost-of-illness study among patients with diabetes mellitus and coping mechanisms in Northern Ghana.
Article in BMJ public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Adverse Drug Reaction Costs and Study Quality in Africa: A Systematic Review of Cost-of-Illness Studies.PharmacoEconomics - open · 2026Pooled it
- Exploring the Socio-Economic Toll of Non-Communicable Diseases in Low-Resource Settings: Novel Evidence From Mozambique.The International journal of health planning and management · 2026Article
- Prognostic value of the cardiometabolic index for cardiovascular outcomes in patients with type 2 diabetes mellitus.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The increasing prevalence of diabetes globally imposes financial burden on individuals, societies and health systems. However, not much is known about the treatment costs of diabetes and the coping mechanisms patients adopt in seeking care in the northern part of Ghana. In this study, we assessed the annual direct, indirect and intangible costs of diabetes mellitus care and related coping mechanisms of patients at the Tamale Teaching Hospital's Diabetic Clinic. Methods: This was a descriptive cross-sectional cost-of-illness study conducted between June and August 2023 among 385 patients with diabetes in the Tamale Teaching Hospital of Ghana. Participants were selected by systematic random sampling. Direct medical costs (summation of cost of medications, investigations and admissions) and direct non-medical costs (cost of food and water, and transportation during hospital visits) together made up direct costs per patient per year. Indirect costs (lost wages as a result of illness or hospital visits) were estimated using the human capital approach. Intangible costs were analysed using a 5-point Likert Scale. Cost-coping mechanisms were obtained from the perspectives of the participants. Results: The mean direct cost per person per year was found to be US$159.70 (95% CI 126.70 to 193.04), with direct medical costs being on average US$186.04 and direct non-medical costs being on average US$15.59, while the mean indirect cost per person per year was US$130.72. Average total cost of illness per person per year was found to be US$290.44 (95% CI 248.64 to 334.70). The study participants often experienced intangible costs such as physical pain, easy fatiguability and diet changes as a result of diabetes and adopted a number of cost-coping mechanisms which included the use of savings, borrowing and reducing medication use. Conclusion: The costs incurred for care of diabetes mellitus in Northern Ghana are substantial, especially in view of Ghana's low minimum wage which was US$1.35 in 2023. This results in the adoption of adverse-cost-coping mechanisms that can drive families into further poverty with detrimental effects on the treatment of diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.